Acylcarnitines activate proinflammatory signaling pathways.
about
The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promiseIncreased palmitate intake: higher acylcarnitine concentrations without impaired progression of β-oxidation.Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection.Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.A comprehensive multiomics approach toward understanding the relationship between aging and dementia.Acylcarnitines: potential implications for skeletal muscle insulin resistance.Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity.Metabolomic fingerprint of heart failure with preserved ejection fraction.Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects.Vitamin E and vitamin C do not reduce insulin sensitivity but inhibit mitochondrial protein expression in exercising obese rats.Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed EnvironmentSexual dimorphism in myocardial acylcarnitine and triglyceride metabolism.Acylcarnitines--old actors auditioning for new roles in metabolic physiology.Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men.Targeted Metabolomics of Nonhuman Primate Serum after Exposure to Ionizing Radiation: Potential Tools for High-throughput BiodosimetryLipid-mediated muscle insulin resistance: different fat, different pathways?Pancreatic islet inflammation: an emerging role for chemokines.Metabolic Alterations Contribute to Enhanced Inflammatory Cytokine Production in Irgm1-deficient Macrophages.Comparison of three patterns of feed supplementation with live Saccharomyces cerevisiae yeast on postweaning diarrhea, health status, and blood metabolic profile of susceptible weaning pigs orally challenged with Escherichia coli F4ac.Novel Molecular Interactions of Acylcarnitines and Fatty Acids with Myoglobin.Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.Proteomic and metabolomic characterization of streptozotocin-induced diabetic nephropathy in TIMP3-deficient mice.Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport.Metabolic pathways at the crossroads of diabetes and inborn errors.Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder.HIV latency is reversed by ACSS2-driven histone crotonylation.Dynamic remodeling of lipids coincides with dengue virus replication in the midgut of Aedes aegypti mosquitoes.CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance.Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes.Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers.Menstrual cycle rhythmicity: metabolic patterns in healthy womenWelding fume exposure is associated with inflammation: a global metabolomics profiling studyVaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot studyIncreasing Acyl CoA thioesterase activity alters phospholipid profile without effect on insulin action in skeletal muscle of rats
P2860
Q26829731-0F03FAF6-DC81-4EC5-ABBA-BF4570B24AE3Q30356864-47F1B1B2-AF5C-48E2-B4E0-CF0DCF4D0176Q33765752-BCDCF5EE-D5DE-4AD2-BBC2-D068DF710DFFQ33892283-384EA428-1005-40EE-BD2D-C6C212928361Q34501570-37D58F7A-FB7B-418D-B01D-9DD459930033Q34847808-64F77EFD-6166-4E44-9FB6-F041D2D5A93DQ35131396-D8AB3030-FB5F-4E69-95E4-8ECBCC18E98AQ35641415-75CDEBC6-1CB5-43FF-B8AF-685B7F9B76DBQ35671689-7206D5BE-87C5-447E-8D74-4D4E43C33749Q36463561-3B525947-D463-4EE1-BE0A-A8FF2309F230Q36745098-EA68E0D0-9ED0-42D3-9C3B-6264C1C59B56Q36899212-9F0F51CF-7E6D-4534-B4EA-E7AEBCD820F7Q37137602-8A9D55EC-B512-4E57-BE6B-C27C969A66D4Q37240351-0A13701D-F41F-4F5F-9564-DAF5669F4DD4Q37339234-EE53C0BD-3AB1-4F72-AF35-33D308A2262CQ37730229-78FADE2C-3D3C-4A4B-AA4A-260DED51DCBEQ38537208-C8C49288-DB89-40FA-B617-F9242F09EA1CQ39249398-3E92F7F1-139B-4D6A-912D-15F338DC6427Q40348070-E5ECA06D-C3E3-4297-9413-7BF9CA641F77Q41198017-78AF3C43-3FA6-478E-AA8F-D250FC5D4985Q45092518-A3303DB8-36E0-4F83-8C63-B82C3067048FQ46105664-9DA94309-A048-4563-9479-3F6B84B7A758Q47363157-C14B3562-DC44-456A-850E-03C6D0440424Q47406292-96F2F474-0E1D-4AEC-9D5F-BCCC578871EAQ47752654-9EAAF4F7-24D3-43CD-B3DC-77C80040DEAAQ47927670-902AB3BF-369C-4547-A198-D3E4AC50768BQ48138093-7266BBBD-BE08-4794-8881-1DE569B03E56Q49851068-8639E988-D6C2-49D3-9876-B0B25E870817Q49979350-EFC0CAA7-74DB-4637-B7C5-A344514CB4E8Q50043583-819EF0FE-7148-4612-9B3B-C31EB2549F66Q52375410-3EBACB2F-A0A1-4FF1-96BF-02E59CF021FEQ52575994-9440F66C-FD11-43F0-9EA6-FC9CEA1E1234Q55230187-D3400EDB-2B98-41FA-8983-F787EA50E822Q55287185-59CDC15D-1272-4F90-85C0-2E40219925CCQ55300818-EA5DCD4E-7901-4E10-9309-80E03900B737Q57062557-D6B4D9C9-9343-48F9-853B-8CDF67B6CDF4Q58720965-F304E251-92F8-466B-9115-121482F8416BQ58722987-E7CF10AC-CEB2-4A0E-80CF-DC71C2CBA194Q58726478-00C2CA05-0C94-4433-BFC7-AAD6E51B38E1
P2860
Acylcarnitines activate proinflammatory signaling pathways.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acylcarnitines activate proinflammatory signaling pathways.
@ast
Acylcarnitines activate proinflammatory signaling pathways.
@en
type
label
Acylcarnitines activate proinflammatory signaling pathways.
@ast
Acylcarnitines activate proinflammatory signaling pathways.
@en
prefLabel
Acylcarnitines activate proinflammatory signaling pathways.
@ast
Acylcarnitines activate proinflammatory signaling pathways.
@en
P2093
P2860
P50
P1476
Acylcarnitines activate proinflammatory signaling pathways.
@en
P2093
Daniel H Hwang
Jennifer M Rutkowsky
Kikumi D Ono-Moore
Shurong Huang
Trina A Knotts
P2860
P304
P356
10.1152/AJPENDO.00656.2013
P577
2014-04-22T00:00:00Z